publication venue for
- Overview of Prospective Investigation of Pulmonary Embolism Diagnosis II.. 32. 2002
- Radioimmunoassay: review of basic principles.. 5. 1975
- Guest Editorial.. 46. 2016
- Hypoxia imaging. Guest editorial.. 45. 2015
- Guest Editorial: new PET radiopharmaceuticals as molecular imaging probes.. 41. 2011
- Current status of radiolabeled peptides in nuclear medicine diagnosis and therapy.. 32. 2002
- Cardiac Imaging With 123I-meta-iodobenzylguanidine and Analogous PET Tracers: Current Status and Future Perspectives. 2020
- Innovations in Nuclear Imaging Instrumentation: Cerenkov Imaging. 2018
- I-131 Metaiodobenzylguanidine Therapy of Pheochromocytoma and Paraganglioma. 2016
- Novel Approaches to Thyroid Cancer Treatment and Response Assessment. 2016
- The Potential of Metabolic Imaging. 2016
- Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology. 2011
- A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new? 2011
- Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid. 2011
- Lymph node dissection in papillary thyroid carcinoma. 2011
- Thyroid cancer--indications and opportunities for positron emission tomography/computed tomography imaging. 2011
- Altered biodistribution of radiopharmaceuticals: role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors. 2010
- Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. 2009
- Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications. 2009
- Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. 2008
- Respiratory motion in positron emission tomography/computed tomography: a review. 2008
- Fundamentals of molecular imaging: rationale and applications with relevance for radiation oncology. 2008
- (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. 2007
- Positron emission tomography for prostate, bladder, and renal cancer. 2004
- Targeted Radionuclide Therapy: A Historical and Personal Review. 2019
- A Perspective of the Future of Nuclear Medicine Training and Certification. 2016
- Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone). 2015
- Multiple myeloma: 18F-FDG-PET/CT and diagnostic imaging. 2015
- Accuracy and precision of radioactivity quantification in nuclear medicine images. 2012
- The next generation of positron emission tomography radiopharmaceuticals in oncology. 2011
- To ablate or not to ablate: issues and evidence involved in 131I ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma. 2011
- PET/CT Imaging and Radioimmunotherapy of Prostate Cancer. 2011
- Radioimmunotherapy of lymphoma: Bexxar and Zevalin. 2010
- Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). 2008
- Perfusion lung scintigraphy for the diagnosis of pulmonary embolism: a reappraisal and review of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis methods. 2008
- Small-scale dosimetry: challenges and future directions. 2008
- The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment. 2001
- Receptor imaging: competitive or complementary to antibody imaging? 1997
- Somatostatin-receptor imaging in lymphoma. 1995
- Advances in ultrasound imaging of venous thrombosis. 1991
- Radiolabeled monoclonal antibodies in the diagnosis and treatment of malignant melanoma. 1989
- Clinical nuclear magnetic resonance imaging of the body. 1983
- Current status of ventilation-perfusion imaging. 1980
- Mechanisms of localization of gallium-67 in tumors. 1978